Effect of add-on medication (with dose increase, combined with anti-leukotriene, combined with steroid nasal spray) for allergic rhinitis patients who are not effective of normal dose of Bepotastine besilate.

Trial Profile

Effect of add-on medication (with dose increase, combined with anti-leukotriene, combined with steroid nasal spray) for allergic rhinitis patients who are not effective of normal dose of Bepotastine besilate.

Discontinued
Phase of Trial: Phase II

Latest Information Update: 09 Aug 2016

At a glance

  • Drugs Bepotastine (Primary) ; Leukotriene inhibitors; Steroids
  • Indications Allergic rhinitis
  • Focus Therapeutic Use
  • Most Recent Events

    • 04 Aug 2016 Status changed from not yet recruiting to discontinued.
    • 06 Oct 2013 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top